<DOC>
	<DOC>NCT01564758</DOC>
	<brief_summary>The purpose of this study is to determine if Linezolid is safe for adult Filipino patients diagnosed with gram positive infections.</brief_summary>
	<brief_title>Post Marketing Surveillance Study on Linezolid</brief_title>
	<detailed_description>The subjects were identified after the physician decided to prescribed the drug to the subject.</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Gram-Positive Bacterial Infections</mesh_term>
	<mesh_term>Linezolid</mesh_term>
	<criteria>Has clinical diagnosis of of the following, including cases with concurrent bacteremia, when suspected or known to be caused by susceptible strains of anaerobic or aerobic gram positive microorganisms nosocomial pneumonia, community acquired pneumonia, complicated skin and skin structure infections, uncomplicated skin and skin structure infection, and vancomycinresistant E. faecium Male or female, 18 years old and above Known hypersensitivity Subjects diagnosed with pure gramnegative infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>non-interventional</keyword>
	<keyword>non-comparative</keyword>
	<keyword>open-label study</keyword>
	<keyword>safety</keyword>
	<keyword>Linezolid</keyword>
	<keyword>gram positive infections</keyword>
	<keyword>Filipino</keyword>
</DOC>